General Information of Drug Off-Target (DOT) (ID: OTMTTDYG)

DOT Name Protein O-mannosyl-transferase TMTC3 (TMTC3)
Synonyms EC 2.4.1.109; Protein SMILE; Transmembrane O-mannosyltransferase targeting cadherins 3; Transmembrane and tetratricopeptide repeat-containing 3
Gene Name TMTC3
Related Disease
Epilepsy ( )
Acute myocardial infarction ( )
Adult lymphoma ( )
Breast cancer ( )
Breast carcinoma ( )
Cardiac failure ( )
Congestive heart failure ( )
Extranodal NK/T-cell Lymphoma ( )
Leukopenia ( )
Lissencephaly 8 ( )
Lymphoma ( )
Myocardial infarction ( )
Myopia ( )
Non-small-cell lung cancer ( )
Pediatric lymphoma ( )
Cobblestone lissencephaly ( )
Intellectual disability ( )
Periventricular nodular heterotopia ( )
Dental caries ( )
Keratoconjunctivitis sicca ( )
UniProt ID
TMTC3_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
EC Number
2.4.1.109
Pfam ID
PF08409 ; PF13431 ; PF13174 ; PF13181
Sequence
MANINLKEITLIVGVVTACYWNSLFCGFVFDDVSAILDNKDLHPSTPLKTLFQNDFWGTP
MSEERSHKSYRPLTVLTFRLNYLLSELKPMSYHLLNMIFHAVVSVIFLKVCKLFLDNKSS
VIASLLFAVHPIHTEAVTGVVGRAELLSSIFFLAAFLSYTRSKGPDNSIIWTPIALTVFL
VAVATLCKEQGITVVGICCVYEVFIAQGYTLPLLCTTAGQFLRGKGSIPFSMLQTLVKLI
VLMFSTLLLVVIRVQVIQSQLPVFTRFDNPAAVSPTPTRQLTFNYLLPVNAWLLLNPSEL
CCDWTMGTIPLIESLLDIRNLATFTFFCFLGMLGVFSIRYSGDSSKTVLMALCLMALPFI
PASNLFFPVGFVVAERVLYVPSMGFCILVAHGWQKISTKSVFKKLSWICLSMVILTHSLK
TFHRNWDWESEYTLFMSALKVNKNNAKLWNNVGHALENEKNFERALKYFLQATHVQPDDI
GAHMNVGRTYKNLNRTKEAEESYMMAKSLMPQIIPGKKYAARIAPNHLNVYINLANLIRA
NESRLEEADQLYRQAISMRPDFKQAYISRGELLLKMNKPLKAKEAYLKALELDRNNADLW
YNLAIVHIELKEPNEALKKNFNRALELNPKHKLALFNSAIVMQESGEVKLRPEARKRLLS
YINEEPLDANGYFNLGMLAMDDKKDNEAEIWMKKAIKLQADFRSALFNLALLYSQTAKEL
KALPILEELLRYYPDHIKGLILKGDILMNQKKDILGAKKCFERILEMDPSNVQGKHNLCV
VYFEEKDLLKAERCLLETLALAPHEEYIQRHLNIVRDKISSSSFIEPIFPTSKISSVEGK
KIPTESVKEIRGESRQTQIVKTSDNKSQSKSNKQLGKNGDEETPHKTTKDIKEIEKKRVA
ALKRLEEIERILNGE
Function
Transfers mannosyl residues to the hydroxyl group of serine or threonine residues. The 4 members of the TMTC family are O-mannosyl-transferases dedicated primarily to the cadherin superfamily, each member seems to have a distinct role in decorating the cadherin domains with O-linked mannose glycans at specific regions. Also acts as O-mannosyl-transferase on other proteins such as PDIA3. Involved in the positive regulation of proteasomal protein degradation in the endoplasmic reticulum (ER), and the control of ER stress response.

Molecular Interaction Atlas (MIA) of This DOT

20 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Epilepsy DISBB28L Definitive Biomarker [1]
Acute myocardial infarction DISE3HTG Strong Biomarker [2]
Adult lymphoma DISK8IZR Strong Genetic Variation [3]
Breast cancer DIS7DPX1 Strong Biomarker [4]
Breast carcinoma DIS2UE88 Strong Biomarker [4]
Cardiac failure DISDC067 Strong Biomarker [5]
Congestive heart failure DIS32MEA Strong Biomarker [5]
Extranodal NK/T-cell Lymphoma DIS72GCL Strong Genetic Variation [6]
Leukopenia DISJMBMM Strong Biomarker [3]
Lissencephaly 8 DISKUZRU Strong Autosomal recessive [7]
Lymphoma DISN6V4S Strong Biomarker [8]
Myocardial infarction DIS655KI Strong Genetic Variation [9]
Myopia DISK5S60 Strong Biomarker [10]
Non-small-cell lung cancer DIS5Y6R9 Strong Genetic Variation [11]
Pediatric lymphoma DIS51BK2 Strong Genetic Variation [3]
Cobblestone lissencephaly DIS56826 moderate Biomarker [12]
Intellectual disability DISMBNXP moderate Genetic Variation [13]
Periventricular nodular heterotopia DISU3ZRI Supportive Autosomal dominant [13]
Dental caries DISRBCMD Limited Biomarker [14]
Keratoconjunctivitis sicca DISNOENH Limited Biomarker [15]
------------------------------------------------------------------------------------
⏷ Show the Full List of 20 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
11 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate increases the expression of Protein O-mannosyl-transferase TMTC3 (TMTC3). [16]
Acetaminophen DMUIE76 Approved Acetaminophen increases the expression of Protein O-mannosyl-transferase TMTC3 (TMTC3). [17]
Cupric Sulfate DMP0NFQ Approved Cupric Sulfate increases the expression of Protein O-mannosyl-transferase TMTC3 (TMTC3). [18]
Ivermectin DMDBX5F Approved Ivermectin decreases the expression of Protein O-mannosyl-transferase TMTC3 (TMTC3). [19]
Vorinostat DMWMPD4 Approved Vorinostat decreases the expression of Protein O-mannosyl-transferase TMTC3 (TMTC3). [20]
Carbamazepine DMZOLBI Approved Carbamazepine affects the expression of Protein O-mannosyl-transferase TMTC3 (TMTC3). [21]
Diethylstilbestrol DMN3UXQ Approved Diethylstilbestrol increases the expression of Protein O-mannosyl-transferase TMTC3 (TMTC3). [22]
Geldanamycin DMS7TC5 Discontinued in Phase 2 Geldanamycin increases the expression of Protein O-mannosyl-transferase TMTC3 (TMTC3). [23]
Bisphenol A DM2ZLD7 Investigative Bisphenol A increases the expression of Protein O-mannosyl-transferase TMTC3 (TMTC3). [24]
Trichostatin A DM9C8NX Investigative Trichostatin A decreases the expression of Protein O-mannosyl-transferase TMTC3 (TMTC3). [25]
Formaldehyde DM7Q6M0 Investigative Formaldehyde increases the expression of Protein O-mannosyl-transferase TMTC3 (TMTC3). [26]
------------------------------------------------------------------------------------
⏷ Show the Full List of 11 Drug(s)

References

1 Self-Management education for adults with poorly controlled epILEpsy [SMILE (UK)]: a randomised controlled trial.Health Technol Assess. 2018 Apr;22(21):1-142. doi: 10.3310/hta22210.
2 Cardioprotective role of zofenopril in hypertensive patients with acute myocardial infarction: a pooled individual data analysis of the SMILE studies.Blood Press. 2017 Aug;26(4):211-219. doi: 10.1080/08037051.2017.1281712. Epub 2017 Feb 3.
3 Pretreatment EBV-DNA copy number is predictive of response and toxicities to SMILE chemotherapy for extranodal NK/T-cell lymphoma, nasal type.Clin Cancer Res. 2012 Aug 1;18(15):4183-90. doi: 10.1158/1078-0432.CCR-12-1064. Epub 2012 Jun 6.
4 Smartphone problem-solving and behavioural activation therapy to reduce fear of recurrence among patients with breast cancer (SMartphone Intervention to LEssen fear of cancer recurrence: SMILE project): protocol for a randomised controlled trial.BMJ Open. 2018 Nov 8;8(11):e024794. doi: 10.1136/bmjopen-2018-024794.
5 A Prospective, Multicenter, Post-Marketing Surveillance Study to Evaluate the Safety and Effectiveness of Tolvaptan in Patients with Reduced, Preserved, and Mid-Range Ejection Fraction Heart Failure.Int Heart J. 2019 Sep 27;60(5):1123-1130. doi: 10.1536/ihj.18-671. Epub 2019 Sep 4.
6 Defining the toxicity of current regimens for extranodal NK/T cell lymphoma: a systematic review and metaproportion.Expert Rev Anticancer Ther. 2019 Jan;19(1):93-104. doi: 10.1080/14737140.2019.1549992. Epub 2018 Nov 23.
7 mSmile is necessary for bronchial smooth muscle and alveolar myofibroblast development. Anat Rec (Hoboken). 2012 Jan;295(1):167-76. doi: 10.1002/ar.21475. Epub 2011 Sep 28.
8 Epstein-Barr virus-associated natural killer/T-cell lymphomas.Best Pract Res Clin Haematol. 2013 Mar;26(1):15-21. doi: 10.1016/j.beha.2013.04.002. Epub 2013 May 25.
9 Efficacy and Safety of Zofenopril Versus Ramipril in the Treatment of Myocardial Infarction and Heart Failure: A Review of the Published and Unpublished Data of the Randomized Double-Blind SMILE-4 Study.Adv Ther. 2018 May;35(5):604-618. doi: 10.1007/s12325-018-0697-x. Epub 2018 Apr 17.
10 Surgical treatment of corneal dermoid by using intrastromal lenticule obtained from small-incision lenticule extraction.Int Ophthalmol. 2020 Jan;40(1):43-49. doi: 10.1007/s10792-019-01201-w. Epub 2019 Nov 17.
11 Factors associated with improvement in symptoms and quality of life for first-line EGFR-tyrosine kinase inhibitor treatment in patients with EGFR-mutated non-small-cell lung cancer - A multicenter prospective SMILE study.J Cancer. 2019 Jul 10;10(17):4151-4158. doi: 10.7150/jca.30507. eCollection 2019.
12 Endoplasmic reticulum transmembrane protein TMTC3 contributes to O-mannosylation of E-cadherin, cellular adherence, and embryonic gastrulation.Mol Biol Cell. 2020 Feb 1;31(3):167-183. doi: 10.1091/mbc.E19-07-0408. Epub 2019 Dec 18.
13 Identification of a novel synaptic protein, TMTC3, involved in periventricular nodular heterotopia with intellectual disability and epilepsy. Hum Mol Genet. 2017 Nov 1;26(21):4278-4289. doi: 10.1093/hmg/ddx316.
14 Development and Relative Validity of a Food Frequency Questionnaire to Assess Intakes of Total and Free Sugars in Australian Toddlers.Int J Environ Res Public Health. 2017 Nov 8;14(11):1361. doi: 10.3390/ijerph14111361.
15 Dry Eye After LASIK.Invest Ophthalmol Vis Sci. 2018 Nov 1;59(14):DES109-DES115. doi: 10.1167/iovs.17-23538.
16 The neuroprotective action of the mood stabilizing drugs lithium chloride and sodium valproate is mediated through the up-regulation of the homeodomain protein Six1. Toxicol Appl Pharmacol. 2009 Feb 15;235(1):124-34.
17 Predictive toxicology using systemic biology and liver microfluidic "on chip" approaches: application to acetaminophen injury. Toxicol Appl Pharmacol. 2012 Mar 15;259(3):270-80.
18 Physiological and toxicological transcriptome changes in HepG2 cells exposed to copper. Physiol Genomics. 2009 Aug 7;38(3):386-401.
19 Quantitative proteomics reveals a broad-spectrum antiviral property of ivermectin, benefiting for COVID-19 treatment. J Cell Physiol. 2021 Apr;236(4):2959-2975. doi: 10.1002/jcp.30055. Epub 2020 Sep 22.
20 Definition of transcriptome-based indices for quantitative characterization of chemically disturbed stem cell development: introduction of the STOP-Toxukn and STOP-Toxukk tests. Arch Toxicol. 2017 Feb;91(2):839-864.
21 Gene Expression Regulation and Pathway Analysis After Valproic Acid and Carbamazepine Exposure in a Human Embryonic Stem Cell-Based Neurodevelopmental Toxicity Assay. Toxicol Sci. 2015 Aug;146(2):311-20. doi: 10.1093/toxsci/kfv094. Epub 2015 May 15.
22 Identification of biomarkers and outcomes of endocrine disruption in human ovarian cortex using In Vitro Models. Toxicology. 2023 Feb;485:153425. doi: 10.1016/j.tox.2023.153425. Epub 2023 Jan 5.
23 Identification of transcriptome signatures and biomarkers specific for potential developmental toxicants inhibiting human neural crest cell migration. Arch Toxicol. 2016 Jan;90(1):159-80.
24 Isobaric tags for relative and absolute quantitation-based proteomics analysis of the effect of ginger oil on bisphenol A-induced breast cancer cell proliferation. Oncol Lett. 2021 Feb;21(2):101. doi: 10.3892/ol.2020.12362. Epub 2020 Dec 8.
25 A transcriptome-based classifier to identify developmental toxicants by stem cell testing: design, validation and optimization for histone deacetylase inhibitors. Arch Toxicol. 2015 Sep;89(9):1599-618.
26 Characterization of formaldehyde's genotoxic mode of action by gene expression analysis in TK6 cells. Arch Toxicol. 2013 Nov;87(11):1999-2012.